Austrália - inglês - Department of Health (Therapeutic Goods Administration)

echo therapeutics pty ltd - trimethoprim, quantity: 160 mg; sulfamethoxazole, quantity: 800 mg - tablet - excipient ingredients: magnesium stearate; povidone; sodium starch glycollate; docusate sodium - upper and lower respiratory tract infections, renal and urinary tract infections; genital tract infections; gastrointestinal tract infections; skin and wound infections; septicaemias and other infections caused by sensitive organisms.

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - sulfamethoxazole,trimethoprim -

Armênia - inglês - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

eumedica pharmaceuticals ag - sulfamethoxazole, trimethoprim - suspension oral - 200mg/5ml+ 40mg/5ml

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - trimethoprim; sulfamethoxazole -

Estados Unidos - inglês - NLM (National Library of Medicine)

remedyrepack inc. - sulfamethoxazole (unii: je42381tnv) (sulfamethoxazole - unii:je42381tnv), trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of bactrim (sulfamethoxazole and trimethoprim) tablets and other antibacterial drugs, bactrim (sulfamethoxazole and trimethoprim) tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. urinary tract infections for the treatment of urinary tract infections due to susceptible strains of the following organisms: escherichia coli , klebsiella species, enterobacter species, morganella morganii , proteus mirabilis and proteus vulgaris . it is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination. acute otitis media for the treatment of acute otitis media in pediatric patients due to susceptible strains of streptococcus pneumoniae or haemophilus influenzae when in the judgment of the physician sulfamethoxazole and trimethoprim offers some advantage over the use of other antimicrobial agents. to date, there are limited data on the safety of repeated use of bactrim in pediatric patients under two years of age. bactrim is not indicated for prophylactic or prolonged administration in otitis media at any age. acute exacerbations of chronic bronchitis in adults for the treatment of acute exacerbations of chronic bronchitis due to susceptible strains of streptococcus pneumoniae or haemophilus influenzae when a physician deems that bactrim could offer some advantage over the use of a single antimicrobial agent. shigellosis for the treatment of enteritis caused by susceptible strains of shigella flexneri and shigella sonnei when antibacterial therapy is indicated. pneumocystis jirovecii pneumonia for the treatment of documented pneumocystis jirovecii pneumonia and for prophylaxis against p. jirovecii pneumonia in individuals who are immunosuppressed and considered to be at an increased risk of developing p. jirovecii pneumonia. traveler's diarrhea in adults for the treatment of traveler's diarrhea due to susceptible strains of enterotoxigenic e. coli . bactrim is contraindicated in the following situations: - a known hypersensitivity to trimethoprim or sulfonamides - history of drug-induced immune thrombocytopenia with use of trimethoprim and/or sulfonamides - documented megaloblastic anemia due to folate deficiency - pediatric patients less than 2 months of age - marked hepatic damage - severe renal insufficiency when renal function status cannot be monitored - concomitant administration with dofetilide (see precautions ).

África do Sul - inglês - South African Health Products Regulatory Authority (SAHPRA)

lebasi pharmaceuticals (pty) ltd - injection - see ingredients - each 5 ml solution contains sulfamethoxazole 400 mg trimethoprim 80 mg

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

echo therapeutics pty ltd - trimethoprim, quantity: 80 mg; sulfamethoxazole, quantity: 400 mg - injection, concentrated - excipient ingredients: ethanol absolute; water for injections; monoethanolamine; propylene glycol; sodium hydroxide - parenteral administration of bactrim is indicated where oral dosage is not desirable or practical, e.g. pre- and post-operative infections associated with surgery, trauma or gynaecology; septicaemia and other infections due to sensitive organisms such as typhoid and paratyphoid.

Estados Unidos - inglês - NLM (National Library of Medicine)

ar scientific, inc. - sulfamethoxazole (unii: je42381tnv) (sulfamethoxazole - unii:je42381tnv) - sulfamethoxazole 800 mg

Filipinas - inglês - FDA (Food And Drug Administration)

jekk-meary pharmaceuticals - amoxicillin (as trihydrate) - capsule - 500mg